Can pregnant women take injectable Arachitol (Vitamin D) 600,000 IU?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin D Supplementation During Pregnancy: Safety of Injectable Arachitol 600,000 IU

Injectable Arachitol (Vitamin D) at a dose of 600,000 IU is not recommended during pregnancy due to safety concerns and lack of evidence supporting such high doses.

Safety Concerns with High-Dose Vitamin D in Pregnancy

The FDA drug label for injectable vitamin D clearly states that animal reproduction studies have shown fetal abnormalities associated with hypervitaminosis D 1. These abnormalities are similar to supravalvular aortic stenosis syndrome characterized by supravalvular aortic stenosis, elfin facies, and mental retardation.

Recommended Dosing During Pregnancy

  • Standard recommendation for vitamin D during pregnancy is only 600 IU (15 mcg) per day 2
  • This is considered the minimum requirement to maintain adequate 25-hydroxyvitamin D concentration above 20 ng/mL (50 nmol/L)
  • The FDA specifically warns that "the safety in excess of 400 USP Units of vitamin D daily during pregnancy has not been established" 1

Evidence-Based Alternatives

Research indicates that even much lower doses than 600,000 IU can be effective:

  • Clinical trials have studied doses ranging from 400-4000 IU/day during pregnancy 3
  • A randomized controlled trial found that 4000 IU/day was safe and most effective in achieving vitamin D sufficiency in pregnant women 3
  • Recent evidence suggests that even 1000 IU/day supplementation may have limited effectiveness in correcting deficiency 4

Risks of Excessive Vitamin D

High-dose vitamin D administration carries significant risks:

  • The FDA warns that "IN VITAMIN D RESISTANT RICKETS THE RANGE BETWEEN THERAPEUTIC AND TOXIC DOSES IS NARROW" 1
  • Hypervitaminosis D can lead to hypercalcemia and potentially harmful effects on both mother and fetus
  • The FDA categorizes vitamin D as Pregnancy Category C, indicating potential risks that should be carefully weighed against benefits 1

Monitoring Requirements

If vitamin D supplementation is deemed necessary:

  • Serum 25(OH)D levels should be monitored at least annually, preferably at the end of darker months 2
  • Additional monitoring 3-6 months after dosage changes is recommended
  • When high therapeutic doses are used, frequent blood calcium determinations are necessary 1

Benefits of Appropriate Vitamin D Supplementation

Adequate (but not excessive) vitamin D supplementation during pregnancy has been associated with:

  • Reduced risk of preterm birth 5
  • Reduced risk of small-for-gestational age/low birth weight infants 5
  • Reduced risk of pre-eclampsia and miscarriage 5
  • Improved fetal growth 6

Conclusion

The proposed dose of 600,000 IU is approximately 1000 times higher than the recommended daily intake of 600 IU. While vitamin D supplementation is important during pregnancy, it should be provided at appropriate doses (typically 600-4000 IU daily) rather than as a single mega-dose injection of 600,000 IU, which poses unnecessary risks to both mother and fetus.

If vitamin D deficiency is a concern, oral supplementation at appropriate doses with regular monitoring is the safer approach.

References

Guideline

Nutrition During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011

Research

Vitamin D supplementation during pregnancy: an overview.

Current opinion in obstetrics & gynecology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.